ArticleHeliyon2024

Trilobolide-6-O-isobutyrate exerts anti-tumor effects on cholangiocarcinoma cells through inhibiting JAK/STAT3 signaling pathway.

Hao-Xuan Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.